DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Ott PA, Bang YJ, Bergon-Rigaud D. et al.
Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1–positive endometrial cancer: results from the KEYNOTE-028 study.
J Clin Oncol 2017;
35: 2535-2541
We do not assume any responsibility for the contents of the web pages of other providers.